Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® (naloxone HCl) Nasal Spray as the first FDA-approved ...
In the whole history of the Orthodox Church in America, this has never been seen,” a priest said about the surge of young men ...
Sean Carlos Payne was sentenced to 35 years in federal prison on charges of sexual exploitation of a minor, among other ...
Agios Pharmaceuticals (AGIO) stock falls as a late-stage trial for its lead drug mitapivat in sickle cell disease indicate a ...
(Reuters) -Federal Reserve Governor Stephen Miran said on Wednesday that easing financial firms' regulatory burden could ...
Which means they’re more likely to be accepted as leaders by their teams. A study published in Journal of Business and ...
Agios Pharmaceuticals, Inc. drops after mixed Phase 3 mitapivat results in Sickle Cell Disease. Click here to find out why ...
Several medical groups are pushing back on planned payment policy changes announced by Anthem Blue Cross Blue Shield, arguing ...
Agentic AI is not just an investment in technology with a fixed term replacement cycle. It can also be an employee, that ...
A local family is demanding answers after their three-year-old needed emergency brain surgery, but the system meant to help ...
He returned to a hero's welcome, but LeBron James didn't come back to be the hero. In a stunning 140-point explosion, the ...
Another issue is the lack of authority to state governments, as the Centre has overriding powers. The legislation, if passed, will have an overriding effect on state legislation for seed trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback